Abstract
Despite the widespread use of stress echocardiography, its reproducibility is still limited by high interobserver variability. Therefore, the purpose of the present study was to improve the reproducibility of a stress (exercise) echocardiography using a new transpulmonary ultrasound agent (BY 963). Stress echocardiography was performed in 12 healthy volunteers with suboptimal endocardial border delineation during exercise echocardiography. A special 45° lateral tilted bike stress echocardiography table was used for exercise testing. Echocardiographic images were recorded on-line at rest and during exercise on a video tape and additionally digitized on-line on a stress echo computer. End-diastolic (EDVml), end-systolic (ESVml) volume and ejection fraction (EF%) were estimated in the 4-chamber view. The measurements were performed before and after injection of 2.5 ml and 5 ml BY963 at rest and in maximal exercise. A new contrast agent (BY 963) leads to a sufficient contrast effect for the left ventricular cavity after intravenous administration and permits a good delineation of left the endocardial border. The interobserver variability was determined using blinded investigation by two observers. The correlation of EDV and ESV determination at rest was r = 0.68/0.33, after 2.5 ml BY 963 r = 0.97/0.93 and after 5 ml BY 963 r = 0.90/0.93. The correlation for EDV and ESV during exercise was r = 0.52/0.33, after 2.5 ml BY 963 r = 0.88/0.80 and after 5 ml BY 963 r = 0.95/0.92. At rest mean EF without contrast was 61 ± 6%/67 ± 7% (r = 0. 130), after 2.5 ml BY 963 i.v. 69 ± 8%/72 ± 7% (r = 0.82) and after 5 ml BY 963 i.v. 73 ± 8%/73 ± 8% (r = 0.98%) respectively. In exercise, mean EF without contrast was 68 ± 8%/70 ± 6 (r = 0.013), after 2.5 ml BY 963 83 ± 6%/81 ± 5 and after 5 ml 83 ± 4%/82 ± 3 (r = 0.86). Summary: The estimation of the end-systolic volume in exercise will be improved significantly and the estimated EF values will be higher compared to EF values obtained without contrast application. Transpulmonary contrast echocardiography for analysis of left ventricular volumes and ejection fraction can be routinely used in stress echocardiography. Intravenous administration of BY 963 improves the reproducibility of quantitative analysis of left ventricular function in healthy volunteers. Further studies in patients with cardiac diseases are required to corroborate this observation.
References
Hecht HS, Debord L, Shaw R, Dunlap R, Ryan C, Stertzer SH, Myler RK. Digital supine bicycle stress echocardiography: a new technique for evaluating coronary artery disease. J Am Coll Cardiol 1993; 21: 950-6.
Hoffmann R, Lethen H, Kleinhans E, Weiss M, Flachskampf F, Hanrath P. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogramm for identification of coronary artery disease. Am J Cardiol 1993; 72: 555-9.
Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992; 19: 74-81.
Leischik R, Adamczewski O, Pötter S, Erbel R, Lösse B. Exercise echocardiography — a new test for the assessment of antiischemic drug effects. Z Kardiol 1995; 84: 621-32.
Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly, Krüger S, Meyer J. Exercise Echocardiography for evaluation of patients after nonsurgical coronary artery revascularization. J Am Coll Cardiol 1993; 21: 1087-93.
Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo FJ. Accuracy and Limitations of exercise Echocardiography in a routine clinical setting. J Am Coll Cardiol 1992; 19: 74-81.
Hoffmann R, Lethen H, Marwick T, Amese M, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flachskampf F, Hanrath P. Reasons for interinstitutional observer varianace in the interpretation of stress echocardiography. J Am Coll Cardiol 1996; 27(Suppl A) 1039-58 (abstr).
Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography: Contrast studies in anatomy and function. Radiol 1968; 92: 939-48.
Ten Cate FJ, Feinstein S, Zwehl W, Ong K, Maurer G, Tei C, Shah PM, Meerbaum S, Corday E. Two-dimensional contrast echocardiography. II Transpulmonary studies. J Am Coll Cardiol 1984; 3: 21-27.
Keller MW, Glasheen W, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr 1989; 2: 48-52.
Feinstein SB, Cheirif J, Ten Cate FJ, Silverman PR, Heidenreich PA, C Dick, Desir RM. Safety and Efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results. J Am Coll Cardiol 1990; 16: 316-24.
Ten Cate FJ, Cornel JH, Widimsky P, Vletter W, Serruys P, Waaler A. Clinical experience with Albunex: A standard echocontrast agent for intravenous and intracoronary use. Am J Cardiac Imaging 1991; 5: 217-223.
Crouse LJ. Sonicated serum albumin in contrast echocardiography: Improved segmental wall motion depiction and implications for stress echocardiography. Am J Cardiol 1992; 69; 42H-45H.
Schröder K, Agrawal R, Völler H, Schlief R, Schröder R. Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SH U 508 A. Int J Cardiac Imag 1994; 10: 45-51.
Beckmann S, Schartl M, Bocksch W, Paeprer H. Stressechokardiography: Assessment of left ventricular function after administration of the transpulmonary contrast agent SHU 508 A. Z Kardiol 1993; 82; 317-23.
Erbel R, Zotz R, Mohr-Kahaly S, Wittlich N, Schön F, Steinmetz E, Brennecke R, Mayer J. Left ventricular contrast echocardiography-echoventriculography. In: Nanda CN, Schlief R (eds). Advances in Echo Imaging using Contrast Enhancement. Dordrecht: Kluwer Academic Publishers 1993.
Grube E, Lampen M, Becher H. Echocontrastventriculography — Estimation of left ventricular function by digital subtractions-echocardiography. Z Kardiol 1986; 75: 650-8.
Belz G.G, Breithaupt K, Butzer R, Bliesath H, De May C. Image quality and safety following intravenous BY 963, a new transpulmonary echo contrast medium in man. J Am Coll Cardiol 1994; Suppl, 24 A (abstr).
R. Leischik, K-D. Beller, R. Erbel. Successful myocardial Opacification from intravenous injection of a new contrast agent. Proceedings of World Ultrasonic Congress 1995; 2 pp 1029-32.
Leischik R, Beller KD, Erbel R. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity. Basic Res Cardiol 1996; 91: 101-9.
Porter TR, Xie F, Kricsfeld A, Chiou, A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994; 23: 1440-3.
Falcone RA, Marcovitz PA, Perez JE, Dittrich HC, Hopkins WE, Armstrong WF. Intravenous albunex during dobutamine stress echocardiography: Enhanced localization of left ventricular endocardial borders. Am Heart J 1995; 130: 254-8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leischik, R., Kuhlmann, C., Bruch, C. et al. Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (by 963). Int J Cardiovasc Imaging 13, 387–394 (1997). https://doi.org/10.1023/A:1005822920962
Issue Date:
DOI: https://doi.org/10.1023/A:1005822920962